Clinical Trials Insight: 700042758
Phase of Trial: Phase III
Latest Information Update: 14 Apr 2010
At a glance
- Drugs Antithrombin alfa (Primary)
- Indications Thrombosis
- Focus Registrational; Therapeutic Use
- Sponsors Lundbeck Inc; rEVO Biologics
- 14 Apr 2010 Initiation of the trial is expected in the second half of 2010, according to a GTC Biotherapeutics media release.
- 24 Mar 2009 New trial record.